IMC Chicago
CMPX icon

IMC Chicago’s Compass Therapeutics CMPX Stock Holding History

IMC Chicago’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$116K Buy
+111,500
New +$230K ﹤0.01% 5974

Other funds holding CMPX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

IMC Chicago's CMPX Position: Q3 2026 in Review

IMC Chicago opened a new position in Compass Therapeutics (CMPX) in Q3 2026: 69,791 shares worth $72.6K. The stake represents ﹤0.01% of the portfolio and ranks #6120 among its holdings.

68 funds tracked by Wall St. Rank hold CMPX as of Q3 2026.

  • IMC Chicago held 69,791 shares of Compass Therapeutics worth $72.6K as of Q3 2026.
  • Compass Therapeutics was a new IMC Chicago position in Q3 2026.
  • Compass Therapeutics made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #6120 holding.
  • 68 funds tracked by Wall St. Rank held Compass Therapeutics as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.